CEO: Dr. Stephen T. Worland Ph.D.

IPO: 2021-03-01

Headquarters: US

Employees: 0

Homepage

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).